Orbimed Advisors LLC Bio Xcel Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding BTAI
# of Institutions
52Shares Held
8.63MCall Options Held
34.5KPut Options Held
59.4K-
Armistice Capital, LLC New York, NY4.32MShares$9.19 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$2.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$938,6590.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$664,4850.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $59.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...